(Q41445515)

30 September 2017

1 reference

title

Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications (English)

1 reference

30 September 2017

1 reference

2

A Markham

0 references

author name string

M I Wilde

series ordinal

1

1 reference

30 September 2017

A Markham

series ordinal

2

1 reference

30 September 2017

publication date

1 November 1996

1 reference

30 September 2017

1 reference

30 September 2017

volume

52

1 reference

30 September 2017

issue

5

1 reference

30 September 2017

page(s)

773-794

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199652050-00010

30 September 2017

exact match

0 references

cites work

Ondasentron in the treatment of diabetic diarrhea

1 reference

12 December 2020

Jaundice with ondansetron

1 reference

12 December 2020

Ondansetron: pharmacology of a specific 5HT3-receptor antagonist

1 reference

12 December 2020

Pharmacokinetics of ondansetron in patients with hepatic insufficiency

1 reference

12 December 2020

Parameters of self-administration of cocaine in rats under a progressive-ratio schedule.

1 reference

12 December 2020

Use of ondansetron for control of projectile vomiting in patients with neurosurgical trauma: two case reports

1 reference

12 December 2020

Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats

1 reference

12 December 2020

Inhibitory effect of ethanol on the 5-hydroxytryptamine-induced Bezold-Jarisch reflex--involvement of peripheral 5-HT3 receptors

1 reference

12 December 2020

Studies on the effects of certain 5-HT-3 receptor antagonists on ethanol preference and withdrawal seizures in the rat

1 reference

12 December 2020

Extrapyramidal reaction caused by ondansetron

1 reference

12 December 2020

Serotoninergic control of gonadotrophin and prolactin secretion in women.

1 reference

12 December 2020

Effect of serotonin 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress

1 reference

12 December 2020

Ondansetron for the treatment of pruritus after spinal opioids.

1 reference

12 December 2020

Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron, and clonidine

1 reference

12 December 2020

The influence of peripheral or central administration of ondansetron on stress-induced gastric ulceration in rats

1 reference

12 December 2020

Effect of Serotonin on the Immunoreactive Thyrotropin-Releasing Hormone Concentrations of the Rat Stomach

1 reference

12 December 2020

A randomized double-blinded comparison of the antiemetic efficacy of ondansetron and droperidol in patients receiving high-dose interleukin-2.

1 reference

12 December 2020

Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents

1 reference

12 December 2020

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

1 reference

12 December 2020

Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin

1 reference

12 December 2020

Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum

1 reference

12 December 2020

GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.

1 reference

12 December 2020

Extrapyramidal reaction caused by ondansetron

1 reference

12 December 2020

Ultrashort noninvasive opiate detoxification.

1 reference

12 December 2020

Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse

1 reference

12 December 2020

Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.

1 reference

12 December 2020

Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.

1 reference

12 December 2020

Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference

1 reference

12 December 2020

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

1 reference

12 December 2020

Ondansetron Clinical Pharmacokinetics

1 reference

12 December 2020

Ondansetron improves cognitive performance in the Morris water maze spatial navigation task.

1 reference

12 December 2020

Rapid intravenous administration of ondansetron or metoclopramide is not associated with cardiovascular compromise in children

1 reference

12 December 2020

Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding

1 reference

12 December 2020

The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig

1 reference

12 December 2020

A pilot study of intravenous ondansetron for hyperemesis gravidarum

1 reference

12 December 2020

Ondansetron metabolism and pharmacokinetics

1 reference

12 December 2020

Ondansetron in the treatment of intractable nausea associated with theophylline toxicity

1 reference

12 December 2020

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists

1 reference

12 December 2020

Involvement of the serotonergic system in ethanol intake in the rat.

1 reference

12 December 2020

Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo.

1 reference

12 December 2020

Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

1 reference

12 December 2020

Ondansetron absorption in adults: effect of dosage form, food, and antacids.

1 reference

12 December 2020

The effect of ondansetron on cognitive performance in the marmoset

1 reference

12 December 2020

Pharmacology of ondansetron

1 reference

12 December 2020

Nausea, abdominal pain and diarrhoea of uncertain cause responding to ondansetron

1 reference

12 December 2020

Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron

1 reference

12 December 2020

Dysphoria after treatment with ondansetron

1 reference

12 December 2020

Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions

1 reference

12 December 2020

Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis

1 reference

12 December 2020

5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.

1 reference

12 December 2020

Ondansetron for pruritus due to cholestasis

1 reference

12 December 2020

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

1 reference

12 December 2020

Treatment of chronic cryptosporidiosis-induced diarrhea with a serotonin receptor antagonist

1 reference

12 December 2020

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist

1 reference

12 December 2020

Ondansetron in treatment of schizophrenia

1 reference

12 December 2020

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

12 December 2020

Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?

1 reference

12 December 2020

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides.

1 reference

12 December 2020

The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine

1 reference

12 December 2020

Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

1 reference

12 December 2020

5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats

1 reference

12 December 2020

Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study

1 reference

12 December 2020

Effects of serotonergic anxiolytics on physical dependence on diazepam in mice.

1 reference

12 December 2020

Improvement of cholestatic pruritus by ondansetron

1 reference

12 December 2020

Pharmacokinetics of intravenous ondansetron in healthy children undergoing ear, nose, and throat surgery.

1 reference

12 December 2020

Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism.

1 reference

12 December 2020

Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome

1 reference

12 December 2020

The role of 5-HT3 receptors in drug dependence.

1 reference

12 December 2020

Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system.

1 reference

12 December 2020

A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea.

1 reference

12 December 2020

5-HT3 receptor antagonists reverse helpless behaviour in rats

1 reference

12 December 2020

The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron

1 reference

12 December 2020

Ondansetron quells drug-resistant emesis in theophylline poisoning

1 reference

12 December 2020

5-hydroxytryptamine 3-receptor antagonist modulates gallbladder emptying and motilin release induced by erythromycin

1 reference

12 December 2020

The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension

1 reference

12 December 2020

Ondansetron for treating nausea and vomiting in the poisoned patient

1 reference

12 December 2020

Anaphylactoid-anaphylactic reactions associated with ondansetron

1 reference

12 December 2020

Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans

1 reference

12 December 2020

Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers

1 reference

12 December 2020

5-Hydroxytryptamine3-receptor blockade protects against gastric mucosal damage in rats

1 reference

12 December 2020

The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment

1 reference

12 December 2020

Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

1 reference

12 December 2020

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

1 reference

12 December 2020

Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats

1 reference

12 December 2020

Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting

1 reference

12 December 2020

Ondansetron in carcinoid syndrome

1 reference

12 December 2020

Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers.

1 reference

12 December 2020

Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication

1 reference

12 December 2020

Ondansetron usage in HIV positive patients: a pilot study on the control of nausea and vomiting in patients on high dose co-trimoxazole for Pneumocystis carinii pneumonia

1 reference

12 December 2020

Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.

1 reference

12 December 2020

Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures

1 reference

12 December 2020

Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex

1 reference

12 December 2020

Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers

1 reference

12 December 2020

Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.

1 reference

12 December 2020

Influence of 5-HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats

1 reference

12 December 2020

Ondansetron for symptomatic relief in terminal uraemia

1 reference

12 December 2020

Ondansetron and hyperemesis gravidarum

1 reference

12 December 2020

Effects of cocaine alone and in combination with prazosin or ondansetron on multiple fixed-interval fixed-ratio performance in pigeons

1 reference

12 December 2020

Ondansetron: indications and applications in the paediatric intensive care unit

1 reference

12 December 2020

Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure.

1 reference

12 December 2020

Serotonin and psychiatric disorders. A key to new therapeutic approaches

1 reference

12 December 2020

Pharmacology and preclinical antiemetic properties of ondansetron

1 reference

12 December 2020

Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset

1 reference

12 December 2020

Psychiatric complications associated with ondansetron

1 reference

12 December 2020

Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.

1 reference

12 December 2020

Managing an extrapyramidal reaction caused by ondansetron.

1 reference

12 December 2020

Cardiovascular stability with rapid intravenous infusion of ondansetron.

1 reference

12 December 2020

Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats

1 reference

12 December 2020

Ondansetron for intractable vertigo complicating acute brainstem disorders

1 reference

12 December 2020

Ondansetron in carcinoid syndrome

1 reference

12 December 2020

Serotonergic mediation of postprandial colonic tonic and phasic responses in humans

1 reference

12 December 2020

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

1 reference

12 December 2020

Ondansetron and hyperemesis gravidarum

1 reference

12 December 2020

Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy

1 reference

12 December 2020

5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.

1 reference

12 December 2020

Anaphylactoid reactions associated with ondansetron

1 reference

12 December 2020

A study to evaluate the effect of ondansetron on psychomotor performance after repeated oral dosing in healthy subjects

1 reference

12 December 2020

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons

1 reference

12 December 2020

Ondansetron and related 5-HT3 antagonists: recent advances

1 reference

12 December 2020

The breadth of action of the 5-HT3 receptor antagonists.

1 reference

12 December 2020

Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan

1 reference

12 December 2020

Modulatory role of 5-HT3 receptors in gastric function and ethanol-induced mucosal damage in rat stomachs

1 reference

12 December 2020

Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers.

1 reference

12 December 2020

Determination of Ondansetron in Plasma and Its Pharmacokinetics in the Young and Elderly

1 reference

12 December 2020

Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats.

1 reference

12 December 2020

Effects of ondansetron pretreatment on acute responses to ethanol in social drinkers.

1 reference

12 December 2020

The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

1 reference

12 December 2020

Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat.

1 reference

12 December 2020

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

12 December 2020

Ondansetron in theophylline overdose

1 reference

12 December 2020

Ondansetron and opiate craving. A novel pharmacological approach to addiction.

1 reference

12 December 2020

[Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors]

1 reference

12 December 2020

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

1 reference

12 December 2020

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

1 reference

12 December 2020

Ondansetron in the treatment of theophylline overdose

1 reference

12 December 2020

The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning

1 reference

12 December 2020

Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.

1 reference

12 December 2020

Ondansetron and alcohol pharmacokinetics

1 reference

12 December 2020

Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.

1 reference

12 December 2020

An examination of the 5-HT3 receptor mediating contraction and evoked [3H]-acetylcholine release in the guinea-pig ileum

1 reference

12 December 2020

Potentiation of physical dependence on diazepam by ondansetron in rats.

1 reference

12 December 2020

Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse

1 reference

12 December 2020

Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

1 reference

12 December 2020

5HT drugs in animal models of anxiety

1 reference

12 December 2020

Seizure associated with ondansetron

1 reference

12 December 2020

The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission

1 reference

12 December 2020

Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow

1 reference

12 December 2020

Serotonin 5-HT3 antagonists fail to affect ethanol self-administration of rats.

1 reference

12 December 2020

5-HT3 receptors: pharmacologic and therapeutic aspects

1 reference

12 December 2020

The effect of ondansetron on gastric emptying in the conscious rat

1 reference

12 December 2020

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

12 December 2020

10.2165/00003495-199652050-00010

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1042459490

0 references

1 reference